How to Value a Home-Based Physical Therapy Business in 2026

Home-based physical therapy — where the therapist goes to the patient rather than the other way around — occupies a growing niche that sits between traditional outpatient PT clinics and home health agencies. It's a model that's gaining traction with an aging population that struggles to travel to clinic appointments, and M&A buyers have noticed.

But valuing these businesses requires understanding their unique economics. They don't have the real estate overhead of clinics, but they also don't have the asset base. Their revenue per visit is often higher, but their therapist utilization is lower due to drive time. I've worked on enough of these transactions to know that generic PT valuation frameworks miss the mark entirely.

The Valuation Range: 3-6x EBITDA

Home-based PT businesses typically trade at 3-6x EBITDA, with the spread driven by therapist count, visit volume, payer mix, and geographic density. At the lower end, you're looking at owner-operated practices with 2-4 therapists, heavy Medicare exposure, and a single metro area. At the upper end, it's 10+ therapists, diversified payer mix with 30%+ commercial insurance, and coverage across multiple geographies.

For smaller operations (under $500K revenue), buyers often use an SDE-based approach, typically 1.5-2.5x SDE. The shift to EBITDA-based valuation happens when the business has enough scale that the owner could be replaced with a clinical director — generally at the 6-8 therapist level.

Why are multiples lower than clinic-based PT (which trades at 5-8x EBITDA)? Two reasons. First, home-based PT has lower barriers to entry — no lease, no equipment, just licensed therapists and a car. Second, the workforce risk is concentrated: if three therapists leave a 10-therapist operation, you've lost 30% of revenue capacity overnight. Clinics have more operational infrastructure that survives staff turnover.

Therapist Count and Utilization

In home-based PT, your therapists are your primary asset. Buyers evaluate therapist count, tenure, licensure type, and productivity with a level of scrutiny that would surprise most sellers.

Count and type. A business with 12 full-time PTs is worth materially more than one with 12 part-time PTs, even at the same visit volume. Full-time therapists signal commitment and capacity stability. Buyers also differentiate between PTs, PTAs (physical therapist assistants), and contract therapists. PTs command higher reimbursement rates on many plans and can perform evaluations that PTAs cannot. A higher PT-to-PTA ratio generally supports a higher multiple.

Utilization and productivity. The key metric is visits per therapist per day. In a clinic setting, 10-14 visits per day is standard. In home health PT, 5-7 visits per day is typical because of drive time between patients. Businesses that achieve 7+ visits per day through smart geographic scheduling — clustering patients in the same neighborhoods on the same days — demonstrate operational sophistication that buyers value highly.

Tenure and retention.If your average therapist has been with you for 3+ years, that's a powerful signal. If you're churning through therapists every 12 months, buyers will assume the problem continues post-acquisition and price in ongoing recruiting costs of $15-25K per therapist replacement.

Visit Volume and Revenue Per Visit

Total visit volume is the top-line driver. Buyers want to see consistent month-over-month visit counts, ideally growing. Erratic volume suggests unstable referral relationships or seasonal patient demand that creates cash flow challenges.

Revenue per visit varies significantly by payer:

• Medicare: $150-190 per visit (2026 rates), set by CMS fee schedule. Predictable but subject to annual updates and potential cuts.
• Commercial insurance: $120-250 per visit depending on plan and negotiated rates. Higher variance but often higher average reimbursement, especially for evaluation visits.
• Medicare Advantage: $110-170 per visit. The fastest-growing segment but often with utilization management that limits visit counts per episode.
• Workers' compensation: $140-220 per visit. Higher reimbursement but significant administrative burden and slower payment.

The blended revenue per visit, combined with visits per therapist per day and therapist count, gives buyers a clear picture of revenue capacity and where the growth levers are. Businesses averaging $180+ per visit with room to add therapists command premium multiples.

Medicare vs. Commercial Mix: The Valuation Swing Factor

Payer mix is where home-based PT valuation gets interesting. Medicare is the dominant payer in home health therapy — often 50-70% of revenue for most operators. That's because the patient population that needs home-based PT skews older and Medicare-eligible.

The problem: Medicare reimbursement is subject to federal policy changes, sequestration cuts, and the perpetual threat of payment reform. Buyers price in this regulatory risk, and it's the primary reason heavy-Medicare practices trade at 3-4x EBITDA rather than 5-6x.

Businesses that have deliberately built commercial insurance volume — through relationships with orthopedic surgeons, sports medicine physicians, and employer health plans — achieve diversification that commands a premium multiple. The magic number I see buyers respond to: commercial insurance comprising 30%+ of total visits. Below that, buyers treat you as a Medicare-dependent business. Above it, the valuation conversation changes.

Medicare Advantage deserves special attention. It's growing rapidly (over 50% of Medicare beneficiaries are now in MA plans), but MA plans often impose prior authorization, visit limits, and lower reimbursement than traditional Medicare. The net effect is lower revenue per episode, even if volume is strong. Track and present your traditional Medicare versus MA breakdown separately — sophisticated buyers will ask.

Geographic Coverage and Density

The geographic footprint of a home-based PT business is a double-edged sword. Broader coverage means a larger addressable market, but it also means more drive time, higher vehicle costs, and harder scheduling logistics.

Buyers strongly prefer geographic density — a concentrated service area where therapists can see 6-7 patients per day without driving more than 15-20 minutes between visits. A business covering a 100-mile radius with therapists driving 45 minutes between patients is operationally inefficient and the EBITDA margins will reflect it.

The best-positioned businesses operate in defined metro areas or suburban zones with established referral relationships at hospitals, skilled nursing facilities, and physician practices within that geography. The density creates a competitive moat — even if a competitor enters the market, your therapists are already optimally routed and your referral sources are already trained to call you first.

What Kills Value in Home-Based PT

Owner as primary therapist.If you're personally treating 40%+ of patients, the business is your personal practice with helpers. Buyers will apply an SDE multiple, not an EBITDA multiple, and they'll want a long transition period. Step out of clinical care and into management at least 12-18 months before selling.

Single referral source dependence.If one hospital system or physician group drives 40%+ of your referrals, that's a concentration risk that gives buyers nightmares. Diversify across multiple hospitals, SNFs, physician practices, and direct-to-consumer marketing channels.

Documentation and compliance gaps.Home health therapy is heavily audited by Medicare. If your documentation doesn't support medical necessity for every visit, you're carrying compliance risk that will show up in due diligence. Buyers will hire a compliance consultant to review a sample of your charts, and deficiencies will either reduce the offer or add indemnification requirements that shift risk back to you.

No scheduling technology. Businesses still managing therapist schedules on spreadsheets or whiteboards signal operational immaturity. Modern route optimization and scheduling software (PointClickCare, Homecare Homebase, or similar) demonstrates scalability and reduces drive time waste.

Positioning for Maximum Value

If you're planning an exit within 2-3 years, focus on these high-impact actions:

Build to 8+ therapists.This is the threshold where buyers start seeing a scalable business rather than a large personal practice. It's also where EBITDA-based multiples start to make sense, which typically produces a higher valuation than SDE-based.

Diversify payer mix. Actively pursue commercial insurance contracts and referral relationships with orthopedic and sports medicine physicians who serve working-age patients with employer insurance. Every point of commercial mix improvement reduces your Medicare dependency discount.

Tighten your geography.It's counterintuitive, but shrinking your service area to improve density can actually increase valuation. Higher visits per therapist per day means higher revenue per therapist, better margins, and a more scalable model.

Invest in compliance infrastructure.Hire or contract with a compliance officer, implement regular chart audits, and maintain documentation that withstands Medicare scrutiny. This isn't just about avoiding problems — it's about giving buyers confidence that the revenue is clean and sustainable.

The Bottom Line

Home-based physical therapy is a growing segment with favorable demographics and increasing demand. But the businesses that command premium valuations are the ones that have solved the operational challenges unique to this model — therapist retention, geographic efficiency, payer diversification, and compliance rigor. Nail those four elements, and you'll find buyers willing to pay at the top of the 3-6x EBITDA range. Neglect them, and you'll be fighting for 2-3x with a long earnout attached.